TherapeuticsMD (TXMD) Divestments (2010 - 2022)

TherapeuticsMD (TXMD) reported Divestments of $223.8 million for Q4 2022, up 168355.64% quarter-over-quarter from -$133000.0 in Q3 2022.

TherapeuticsMD (TXMD) Divestments (2010 - 2022) Analysis & Trends

TherapeuticsMD has reported Divestments for 2 years, with the latest figure at $223.8 million in Q4 2022.

For the quarter ending Q4 2022, Divestments changed N/A year-over-year to $223.8 million; the trailing twelve-month figure through Dec 2023 stood at $223.6 million (changed 0.08% YoY), and the FY2022 full-year result was $223.8 million, changed N/A from the prior year.
Divestments for Q4 2022 stood at $223.8 million, up from -$133000.0 in the prior quarter.
The five-year high for Divestments was $223.8 million in Q4 2022, with the low at -$119.8 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	42.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	63.20 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	24.21 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-
10	TherapeuticsMD	21,527.64	-8.40 Mn	-	-

Download Data